Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).
This study has been terminated.
Study NCT00267280   Information provided by Pfizer

First Received on December 19, 2005.   Last Updated on February 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperlipidemia
Dyslipidemia
Hypercholesterolemia
Additional conditions recognized in this trial
Dyslipidemias
Hyperlipidemias
More general conditions related to this trial
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
torcetrapib/atorvastatin
simvastatin
Additional drug interventions recognized in this trial
Atorvastatin
Torcetrapib
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services